Dengue

scientific article

Dengue is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJMRA1110265
P3181OpenCitations bibliographic resource ID138761
P698PubMed publication ID22494122

P50authorNguyen Van Vinh ChauQ30004276
Bridget WillsQ30112202
Cameron P. SimmonsQ37392993
Jeremy FarrarQ15967402
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectDengue virusQ476209
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)1423-32
P577publication date2012-04-12
P1433published inThe New England Journal of MedicineQ582728
P1476titleDengue
P478volume366

Reverse relations

cites work (P2860)
Q3025099318F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response
Q27926246A Cluster-Randomized Controlled Trial to Reduce Diarrheal Disease and Dengue Entomological Risk Factors in Rural Primary Schools in Colombia
Q36242853A Cohort Study of Adult Patients with Severe Dengue in Taiwanese Intensive Care Units: The Elderly and APTT Prolongation Matter for Prognosis.
Q33422520A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice
Q35577798A Prognostic Model for Development of Profound Shock among Children Presenting with Dengue Shock Syndrome
Q35928781A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children
Q33411427A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion
Q56651783A comparative analysis of three different methods for the estimation of the basic reproduction number of dengue
Q66679094A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon
Q63740000A cross-sectional survey on the seroprevalence of dengue fever in febrile patients attending health facilities in Cross River State, Nigeria
Q92320345A dengue fever predicting model based on Baidu search index data and climate data in South China
Q30665268A dengue outbreak on a floating village at Cat Ba Island in Vietnam
Q38394524A device architecture for three-dimensional, patterned paper immunoassays.
Q40135325A fatal case of primary dengue infection with myocarditis and cerebral oedema
Q91685945A global model for predicting the arrival of imported dengue infections
Q41930017A lethal model of disseminated dengue virus type 1 infection in AG129 mice
Q38992578A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases
Q35022038A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease
Q38786420A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone
Q35096730A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Q114704050A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
Q59360698A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate
Q40180446A plasmid-based reporter system for live cell imaging of dengue virus infected cells
Q38908540A pregnant woman with acute cardiorespiratory failure: dengue myocarditis
Q94452539A prospective 3 year study of clinical spectrum and outcome of dengue fever in ICU from a tertiary care hospital in North India
Q38658737A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
Q36607295A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial
Q35014982A systematic review and meta-analysis of dengue risk with temperature change
Q47111949A systematic review of the economic impact of rapid diagnostic tests for dengue
Q27468820Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes
Q37112881Acute renal failure due to rhabdomyolysis following dengue viral infection: a case report
Q39229727Adjuvant PIKA protects hepatoma cells from dengue virus infection by promoting a TBK-1-dependent innate immune response
Q44840552After the FEAST--fluid resuscitation in pediatric sepsis.
Q25160820Alarm Variables for Dengue Outbreaks: A Multi-Centre Study in Asia and Latin America
Q40040951Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression
Q28114617An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting
Q38664968An Overview of Animal Models for Arthropod-Borne Viruses
Q40171566An Unusual Case of Osteonecrosis of Jaw associated with Dengue fever and Periodontitis
Q34353489An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.
Q24290781An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito
Q44843450Analysing increasing trends of Guillain-Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data
Q26700072Anti-flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues
Q34550268Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.
Q36628520Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy
Q52652259Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2.
Q56479686Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM)
Q39370376Antiviral activity of Carbenoxolone disodium against dengue virus infection
Q35085660Antiviral macrophage responses in flavivirus encephalitis
Q40230111Apoptotic mediators in patients with severe and non-severe dengue from Brazil
Q63739951Application of a targeted-enrichment methodology for full-genome sequencing of Dengue 1-4, Chikungunya and Zika viruses directly from patient samples
Q52647635Applications of gold nanoparticles in virus detection.
Q26859651Approaches to refining estimates of global burden and economics of dengue
Q56797874Arbovirus Surveillance near the Mexico-U.S. Border: Isolation and Sequence Analysis of Chikungunya Virus from Patients with Dengue-like Symptoms in Reynosa, Tamaulipas
Q57008751Arboviruses and pregnancy: maternal, fetal, and neonatal effects
Q56797968Ask the Experts: Surveillance of global dengue distribution
Q37533789Assembly of the genome of the disease vector Aedes aegypti onto a genetic linkage map allows mapping of genes affecting disease transmission
Q92936610Assessing dengue control in Tokyo, 2014
Q34550185Assessing positivity and circulating levels of NS1 in samples from a 2012 dengue outbreak in Rio de Janeiro, Brazil
Q37152700Assessing socioeconomic vulnerability to dengue fever in Cali, Colombia: statistical vs expert-based modeling
Q34479588Assessing the epidemiological effect of wolbachia for dengue control
Q30862635Assessing the methods needed for improved dengue mapping: a SWOT analysis
Q28656188Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence
Q51149102Assessment of Aedes albopictus reference genes for quantitative PCR at different stages of development.
Q33723518Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
Q60956543Assessment of metagenomic Nanopore and Illumina sequencing for recovering whole genome sequences of chikungunya and dengue viruses directly from clinical samples
Q40167189Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in Adults
Q37597445Association DENV1 and DENV2 infection with high serum levels of soluble thrombomodulin and VEGF in patients with dengue fever and dengue hemorrhagic fever
Q36487320Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients
Q27468948Association of BAK1 single nucleotide polymorphism with a risk for dengue hemorrhagic fever
Q37161920Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study
Q98174618Association of genotype III of dengue virus serotype 3 with disease outbreak in Eastern Sudan, 2019
Q92845746Asymptomatic Dengue Virus Infections, Cambodia, 2012-2013
Q34352267Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.
Q58701074B cell subset alteration and the expression of tissue homing molecules in dengue infected patients
Q40094919B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue
Q38905651Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.
Q21562283Big data opportunities for global infectious disease surveillance
Q40040211Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey
Q24570070Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells
Q40251552Breast milk as a possible route of vertical transmission of dengue virus?
Q89733973C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study
Q35760439CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
Q39085489CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety
Q30361134Cardiovascular manifestations of the emerging dengue pandemic.
Q40241605Cellulose-based diagnostic devices for diagnosing serotype-2 dengue fever in human serum
Q97521483Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
Q52692686Characteristics and predictors for gastrointestinal hemorrhage among adult patients with dengue virus infection: Emphasizing the impact of existing comorbid disease(s).
Q47558465Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants
Q52646073Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
Q66678846Characterization of clinical patterns of dengue patients using an unsupervised machine learning approach
Q36255068Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model
Q37327964Characterization of the Myocarditis during the worst outbreak of dengue infection in China
Q38260350Chlorophyll derivatives can be an efficient weapon in the fight against dengue
Q41928393Chymase is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients
Q57100423Circulating dengue virus serotypes in Bangladesh from 2013 to 2016
Q27468814Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat
Q30893969Climate change and vector-borne diseases: what are the implications for public health research and policy?
Q93046783Climate change impact on migration, travel, travel destinations and the tourism industry
Q57148624Clinical Features and Laboratory Findings of Travelers Returning to South Australia with Dengue Virus Infection
Q33629506Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever
Q50532065Clinical and Hematological Profile of Patients with Dengue Fever at a Tertiary Care Hospital - An Observational Study.
Q33432889Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015.
Q33757489Clinical and virological characteristics of dengue in Surabaya, Indonesia
Q40039687Clinical application of modified bag-of-features coupled with hybrid neural-based classifier in dengue fever classification using gene expression data
Q37272298Clinical characteristics of Dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital
Q35954329Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries
Q35140633Clinical features of and risk factors for rhabdomyolysis among adult patients with dengue virus infection
Q33841065Clinical presentation of dengue by serotype and year of epidemic in Martinique
Q92860618Clinical prognostic models for severe dengue: a systematic review protocol
Q24701811Co-distribution and co-infection of chikungunya and dengue viruses
Q99634058Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge
Q37734037Comments on the clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile
Q36078741Comparative Susceptibility of Aedes albopictus and Aedes aegypti to Dengue Virus Infection After Feeding on Blood of Viremic Humans: Implications for Public Health
Q34143958Comparative assessment of the bacterial communities associated with Aedes aegypti larvae and water from domestic water storage containers.
Q99411828Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia
Q56748346Complementary and alternative medicine in alliance with conventional medicine for dengue therapeutics and prevention
Q35758626Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies
Q64101350Concurrent infections of dengue virus serotypes in Bali, Indonesia
Q34500917Considerations in the design of clinical trials to test novel entomological approaches to dengue control
Q91807708Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention
Q43046807Construction and Identification of Recombinant HEK293T Cell Lines Expressing Non-structural Protein 1 of Zika Virus
Q40198029Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone
Q37619957Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations
Q28550365Copulation Activity, Sperm Production and Conidia Transfer in Aedes aegypti Males Contaminated by Metarhizium anisopliae: A Biological Control Prospect
Q89868562Coronary Artery Spasms Mimicking Acute ST-Elevation Myocardial Infarction in Dengue Haemorrhagic Fever
Q34779065Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans
Q35590817Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients
Q22918883Corticosteroids for dengue infection
Q36404706Cost implications of implementation of pathogen-inactivated platelets
Q47578242Cost-effectiveness of dengue vaccination in ten endemic countries
Q30250932Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
Q47196084Critical low temperature for the survival of Aedes aegypti in Taiwan
Q34354665Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins
Q38661075Current issues in the economics of vaccination against dengue
Q38992396Current management of severe dengue infection
Q33408300Current progress in dengue vaccines
Q38157397DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Q38740182Delayed care-seeking and outcome of dengue-infected patients
Q91271250Dengue
Q26314480Dengue Deaths: Associated Factors and Length of Hospital Stay
Q27304342Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
Q33423535Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody
Q39371396Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement
Q40133947Dengue Human Infection Models to Advance Dengue Vaccine Development
Q59359154Dengue Infection Spectrum in Guangzhou: A Cross-Sectional Seroepidemiology Study among Community Residents between 2013 and 2015
Q28087420Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control
Q38963303Dengue Virus Exposures Among Deployed U.S. Military Personnel
Q27316360Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins
Q35833914Dengue Virus Infection Causes the Activation of Distinct NF-κB Pathways for Inducible Nitric Oxide Synthase and TNF-α Expression in RAW264.7 Cells
Q35641205Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Q36280060Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs.
Q65000498Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.
Q99574588Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
Q35050760Dengue and its effects on liver
Q50793626Dengue as a cause of fever during pregnancy: a report of two cases.
Q97525857Dengue awareness and its determinants among urban adults of Rohtak, Haryana
Q35598958Dengue disease outbreak definitions are implicitly variable
Q35574035Dengue epidemiology in selected endemic countries: factors influencing expansion factors as estimates of underreporting.
Q34320466Dengue expansion in Africa-not recognized or not happening?
Q49940527Dengue fever : Symptoms, epidemiology, entomology, pathogen diagnosis and prevention
Q33427475Dengue fever as a cause of hemophagocytic lymphohistiocytosis
Q39146003Dengue fever complicated by hemophagocytosis.
Q30245613Dengue fever virus in Pakistan: effects of seasonal pattern and temperature change on distribution of vector and virus
Q41930015Dengue fever. Clinical features of 567 consecutive patients admitted to a tertiary care center in Saudi Arabia.
Q28651505Dengue fever: a Wikipedia clinical review
Q39590469Dengue human infection models supporting drug development
Q38386336Dengue human infection models to advance dengue vaccine development
Q35692481Dengue in adults admitted to a referral hospital in Hanoi, Vietnam
Q36433186Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?
Q34766802Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters
Q40056062Dengue infection during pregnancy and risk of preterm birth
Q42996339Dengue infection.
Q35458940Dengue on islands: a Bayesian approach to understanding the global ecology of dengue viruses
Q55046089Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).
Q34042859Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection
Q37270826Dengue serotype immune-interactions and their consequences for vaccine impact predictions
Q33406567Dengue surveillance in Veterans Affairs healthcare facilities, 2007-2010
Q28542607Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions
Q38732727Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission
Q90197644Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies
Q33976500Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation
Q39606954Dengue virus infection induces formation of G3BP1 granules in human lung epithelial cells
Q47555963Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells
Q39500287Dengue virus persists and replicates during storage of platelet and red blood cell units.
Q37694855Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice
Q36267622Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus.
Q56476041Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia
Q34718200Dengue virus type 3 adaptive changes during epidemics in São Jose de Rio Preto, Brazil, 2006-2007.
Q26751422Dengue virus: A global human threat: Review of literature
Q27927998Dengue with a morbilliform rash and a positive tourniquet test
Q62485221Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia
Q91589943Dengue, chikungunya, and scrub typhus are important etiologies of non-malarial febrile illness in Rourkela, Odisha, India
Q40215531Dengue: "plus ça change, plus c'est la même chose".
Q27010609Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment
Q47103344Dengue: The break-bone fever outbreak in Kerala, India
Q59352698Dengue: a growing threat requiring vaccine development for disease prevention
Q39597018Dengue: update on epidemiology
Q27468688DengueME: A Tool for the Modeling and Simulation of Dengue Spatiotemporal Dynamics
Q96221013DenvInD: dengue virus inhibitors database for clinical and molecular research
Q36689564Detection of DENV-4 genotype I from mosquitoes collected in the city of Manaus, Brazil
Q35760466Determinants of Dengue Virus NS4A Protein Oligomerization
Q36669080Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico
Q35058916Developing a social autopsy tool for dengue mortality: a pilot study
Q64125827Development of Dengue-type NS1 ELISA for Rapid Detection and Differentiation of Dengue Serotypes during Early Infection
Q36862355Development of a Simple Clinical Risk Score for Early Prediction of Severe Dengue in Adult Patients
Q57030919Development of standard clinical endpoints for use in dengue interventional trials
Q28357303Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study
Q35124863Diagnosing dengue at the point-of-care: utility of a rapid combined diagnostic kit in Singapore
Q35910821Diagnostic accuracy of peripheral venous lactate and the 2009 WHO warning signs for identifying severe dengue in Thai adults: a prospective observational study
Q36639140Diarrhea and dengue control in rural primary schools in Colombia: study protocol for a randomized controlled trial
Q58778953Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore
Q57064402Different aspects of platelet evaluation in dengue: measurement of circulating mediators, ability to interact with the virus, the degree of activation and quantification of intraplatelet protein content
Q35130239Differential susceptibility of two field aedes aegypti populations to a low infectious dose of dengue virus
Q53409127Direct Growth of Bacteria in Headspace Vials Allows for Screening of Volatiles by Gas Chromatography Mass Spectrometry.
Q34408025Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus
Q36048467Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection
Q91973559Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease
Q33567787Disease Burden of Dengue in the Philippines: Adjusting for Underreporting by Comparing Active and Passive Dengue Surveillance in Punta Princesa, Cebu City
Q30236000Disease and economic burdens of dengue
Q35837142Dispersal of Engineered Male Aedes aegypti Mosquitoes
Q33728716Dissecting the human serum antibody response to secondary dengue virus infections
Q56000986Distinguishing Zika and Dengue Viruses through Simple Clinical Assessment, Singapore
Q52671501Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease.
Q28119735Diversity of Cultivable Midgut Microbiota at Different Stages of the Asian Tiger Mosquito, Aedes albopictus from Tezpur, India
Q37089546Dogma in classifying dengue disease
Q35107319Dynamic spatiotemporal trends of dengue transmission in the Asia-Pacific region, 1955-2004.
Q57583841Economic Valuation of the Threat Posed by the Establishment of the Asian Tiger Mosquito in Australia
Q35192267Economic and disease burden of dengue in Mexico
Q21092274Economic and disease burden of dengue in Southeast Asia
Q61798363Economic burden of dengue in Indonesia
Q92054238Economic impact of dengue fever in Latin America and the Caribbean: a systematic review
Q56669647Effective surveillance systems for vector-borne diseases in urban settings and translation of the data into action: a scoping review
Q30250906Effects of local and regional climatic fluctuations on dengue outbreaks in southern Taiwan
Q34422058Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Q52602680Efficacy of Aedes aegypti control by indoor Ultra Low Volume (ULV) insecticide spraying in Iquitos, Peru.
Q90516574Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial
Q92648804Emerging and threatening vector-borne zoonoses in the world and in Europe: a brief update
Q63246190Endogenous non-retroviral elements in genomes of Aedes mosquitoes and vector competence
Q39609743Endothelial nitric oxide pathways in the pathophysiology of dengue: a prospective observational study
Q57040576Endothelins in inflammatory neurological diseases
Q36160341Enhanced Surveillance for Fatal Dengue-Like Acute Febrile Illness in Puerto Rico, 2010-2012.
Q33411935Enhanced arbovirus surveillance with deep sequencing: Identification of novel rhabdoviruses and bunyaviruses in Australian mosquitoes
Q36363996Enhanced performance of an innovative dengue IgG/IgM rapid diagnostic test using an anti-dengue EDI monoclonal antibody and dengue virus antigen
Q29196526Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Q48508987Entomopathogenic fungi and their potential for the management of Aedes aegypti (Diptera: Culicidae) in the Americas
Q26314700Epidemic resurgence of dengue fever in Singapore in 2013-2014: A virological and entomological perspective
Q51784584Epidemiological Characteristics and Space-Time Analysis of the 2015 Dengue Outbreak in the Metropolitan Region of Tainan City, Taiwan.
Q92492554Epidemiological and Evolutionary Analysis of Dengue-1 Virus Detected in Guangdong during 2014: Recycling of Old and Formation of New Lineages
Q64064740Epidemiological and clinical characteristics of Dengue virus outbreaks in two regions of China, 2014 - 2015
Q90578267Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study
Q47095800Epidemiological characteristics of dengue disease in Saurashtra region, India, during year 2015.
Q47192433Epidemiological, Serological, and Virological Features of Dengue in Nha Trang City, Vietnam
Q39530072Epidemiology and Disease Burden of Pediatric Dengue in Venezuela
Q39557229Essential oils with insecticidal activity against larvae of Aedes aegypti (Diptera: Culicidae).
Q34766904Estimates of dengue force of infection in children in Colombo, Sri Lanka
Q31113799Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries
Q64962715Estimating Past, Present, and Future Trends in the Global Distribution and Abundance of the Arbovirus Vector Aedes aegypti Under Climate Change Scenarios.
Q35448628Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.
Q50299354Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection
Q37125047Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection
Q40243832Evaluation of cardiac involvement during dengue viral infection
Q34448752Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples
Q39403339Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.
Q37734091Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil
Q40126576Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil
Q35751710Evaluation of the diagnostic accuracy of nonstructural protein 1 Ag-based tests for dengue virus in Asian population: a meta-analysis
Q26315207Evaluation of the vector competence of a native UK mosquito Ochlerotatus detritus (Aedes detritus) for dengue, chikungunya and West Nile viruses
Q38742066Evasion of early innate immune response by 2'-O-methylation of dengue genomic RNA.
Q24289635Expanded Spectrum of Congenital Ocular Findings in Microcephaly with Presumed Zika Infection
Q34640293Experimental inoculation of Artibeus jamaicensis bats with dengue virus serotypes 1 or 4 showed no evidence of sustained replication.
Q36586306Experimental therapies for yellow fever
Q90748722Exploring Epidemiological Characteristics of Domestic Imported Dengue Fever in Mainland China, 2014-2018
Q41919588Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System
Q38905583Exploring the possibility of arthropod transmission of HCV.
Q30423742Extensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses.
Q45434695Fascinating interaction between host and pathogen
Q33415622Fatal outcome of infection by dengue 4 in a patient with thrombocytopenic purpura as a comorbid condition in Brazil
Q38615396Fc receptors in antibody-dependent enhancement of viral infections
Q40215258Field validation of the gravid Aedes trap (GAT) for collection of Aedes aegypti (Diptera: Culicidae).
Q60913859Fine-scale spatial and temporal dynamics of kdr haplotypes in Aedes aegypti from Mexico
Q31156754First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies
Q55452101First report on the application of near-infrared spectroscopy to predict the age of Aedes albopictus Skuse.
Q38964006Flavivirus RNA transactions from viral entry to genome replication
Q90798978Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis
Q30857727Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus
Q90669557Future risk of dengue fever to workforce and industry through global supply chain
Q37432401Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection.
Q34917119Genetic mapping of specific interactions between Aedes aegypti mosquitoes and dengue viruses
Q92416661Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries
Q34639559Genetic variants of MICB and PLCE1 and associations with non-severe dengue
Q33785152Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue
Q28073351Genomic approaches for understanding dengue: insights from the virus, vector, and host
Q39078484Genomics, proteomics and evolution of dengue virus
Q40046100Global Epidemiology of Dengue Outbreaks in 1990-2015: A Systematic Review and Meta-Analysis
Q64075555Global warming and arboviral infections
Q90099025Glycyrrhizic acid derivatives as Dengue virus inhibitors
Q92802144Heatwaves and dengue outbreaks in Hanoi, Vietnam: New evidence on early warning
Q40198146High dengue NS1 antigenemia in febrile patients in Ibadan, Nigeria
Q27928048High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil
Q90129869High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity
Q36669119High mobility group box 1 protein as an auxiliary biomarker for dengue diagnosis
Q89467154High prevalence of Phasi Charoen-like virus from wild-caught Aedes aegypti in Grenada, W.I. as revealed by metagenomic analysis
Q93140606Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope
Q36895627Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes
Q36545428House-to-house human movement drives dengue virus transmission
Q42370266Household costs of hospitalized dengue illness in semi-rural Thailand
Q41921547How does competition among wild type mosquitoes influences the performance of Aedes aegypti and dissemination of Wolbachia pipientis?
Q36322128Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents
Q27468843Human heme oxygenase 1 is a potential host cell factor against dengue virus replication
Q39143936IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection
Q35807844Identification of clinical factors associated with severe dengue among Thai adults: a prospective study
Q40058742Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database
Q43046909Identification of novel antiviral of fungus-derived brefeldin A against dengue viruses
Q37372595Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil
Q47584703Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.
Q39410861Immunopathogenesis Versus Protection in Dengue Virus Infections
Q30151102Impact of human mobility on the emergence of dengue epidemics in Pakistan
Q92239353Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease
Q45349238Implications of a possible route of vertical transmission of dengue virus by breast milk
Q30811442Important vector-borne infectious diseases among humans in Germany. Epidemiological aspects
Q92002145Importation of dengue, Zika and chikungunya infections in Europe: the current situation in Greece
Q30250977In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
Q60921167Incidence and Outcome of Severe and Nonsevere Thrombocytopenia Associated With Zika Virus Infection-Puerto Rico, 2016
Q92638319Incidence dynamics and investigation of key interventions in a dengue outbreak in Ningbo City, China
Q56880391Increased Adult Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae) Abundance in a Dengue Transmission Hotspot, Compared to a Coldspot, within Kaohsiung City, Taiwan
Q37743291Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity
Q40233196Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes' mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication.
Q36305179Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue 4 cases.
Q56428059Inferences about spatiotemporal variation in dengue virus transmission are sensitive to assumptions about human mobility: a case study using geolocated tweets from Lahore, Pakistan
Q91962220Insight into the Tropism of Dengue Virus in Humans
Q92419130Inter-outbreak stability reflects the size of the susceptible pool and forecasts magnitudes of seasonal epidemics
Q34633606International dispersal of dengue through air travel: importation risk for Europe
Q27334417Intra-epidemic evolutionary dynamics of a Dengue virus type 1 population reveal mutant spectra that correlate with disease transmission
Q91605068Intra-host growth kinetics of dengue virus in the mosquito Aedes aegypti
Q36251262Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8+ T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways
Q28656119Investigation of the First Case of Dengue Virus Infection Acquired in Western Australia in Seven Decades: Evidence of Importation of Infected Mosquitoes?
Q38870485Investigational drugs in early development for treating dengue infection.
Q24288742Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis
Q40162717Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever?
Q92728260Isolation and characterization of exosomes released from mosquito cells infected with dengue virus
Q35998523Knowledge, attitudes, and practices of Florida physicians regarding dengue before and after an educational intervention
Q37599853LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection
Q27349518Laser induced mortality of Anopheles stephensi mosquitoes
Q39633694Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors
Q36615111Lessons from malaria control to help meet the rising challenge of dengue
Q37599913Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue
Q33916139Long-term and seasonal dynamics of dengue in Iquitos, Peru
Q37706823Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
Q40218605Loss of appetite and strength in the geriatric population: diagnostic symptoms for dengue
Q38056781Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
Q36497872Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
Q39001736Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010.
Q33439479Management dilemmas in a rare case of pituitary apoplexy in the setting of dengue hemorrhagic fever
Q55514508Mapping dengue risk in Singapore using Random Forest.
Q28114614Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination
Q60924527Mapping the global potential distributions of two arboviral vectors Aedes aegypti and Ae. albopictus under changing climate
Q40152339Mast cell-macrophage dynamics in modulation of dengue virus infection in skin
Q33430984Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage
Q50151207Measles-derived vaccines to prevent emerging viral diseases
Q91904637Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection
Q35935426Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes
Q49789764Metformin Use and Severe Dengue in Diabetic Adults.
Q40242070Micro-spot with integrated pillars (MSIP) for detection of dengue virus NS1.
Q99578541Migration rate estimation in an epidemic network
Q37443189Mitigating the Risk of Transfusion-Transmitted Dengue in Australia
Q66679472Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure
Q35326145Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti
Q100503905Modeling the potential of wAu-Wolbachia strain invasion in mosquitoes to control Aedes-borne arboviral infections
Q98943898Modeling the relative role of human mobility, land-use and climate factors on dengue outbreak emergence in Sri Lanka
Q27468650Molecular Characterization and Viral Origin of the 2015 Dengue Outbreak in Xishuangbanna, Yunnan, China
Q60300856Molecular detection of dengue virus in patients suspected of Ebola virus disease in Ghana
Q27787393Molecular surveillance of dengue in Minas Gerais provides insights on dengue virus 1 and 4 circulation in Brazil
Q34952289Molecular surveillance of dengue in Semarang, Indonesia revealed the circulation of an old genotype of dengue virus serotype-1.
Q88532432Monoclonal antibodies as anti-infective products: a promising future?
Q38059522Mosquito ecology and control of malaria
Q28078140Mosquito-transmitted viruses - the great Brazilian challenge
Q24276139Mouse models of dengue virus infection for vaccine testing
Q58566114Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells
Q40062309Mutagenesis of Dengue Virus Protein NS2A Revealed a Novel Domain Responsible for Virus-Induced Cytopathic Effect and Interactions between NS2A and NS2B Transmembrane Segments
Q90277206Myocarditis Following Recent Chikungunya and Dengue Virus Coinfection: A Case Report
Q24194181NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries
Q40222284NS1 antigen testing for the diagnosis of dengue in returned Israeli travelers
Q38221220Natural products as source of potential dengue antivirals
Q27680452Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus
Q41919556Neurological Complications in a Polynesian Traveler with Dengue
Q54319582Neurological Manifestations of Dengue Infection.
Q28296618Neurological complications of dengue virus infection
Q39512343Neurological manifestations of dengue in Central Brazil
Q28075970Neutrophil Extracellular Traps Go Viral
Q38093249New development in the diagnosis of dengue infections
Q27014786New generation humanized mice for virus research: comparative aspects and future prospects
Q38646923New insights into the immunopathology and control of dengue virus infection
Q33425587New parameters available on Sysmex XE-5000 hematology analyzers contribute to differentiating dengue from leptospirosis and enteric fever
Q36797668No evidence for local adaptation of dengue viruses to mosquito vector populations in Thailand
Q38605200Nucleic acid (DNA) immunization as a platform for dengue vaccine development
Q54232437Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Q37623264Occurrence and correlates of symptom persistence following acute dengue fever in Peru.
Q40256314Ogilvie's syndrome in severe dengue
Q86266160Ophthalmic complications of dengue: pathogenesis and prevention
Q28081774Overcoming tumor immune evasion with an unique arbovirus
Q40132249PUBLIC HEALTH. Dengue vaccines at a crossroad
Q40122173Paediatric Dengue Fever diagnosed through parents' epidemiologic report and preventive strategy during the acute phase of infection
Q38749029Paper-based point-of-care testing for diagnosis of dengue infections
Q89992595Paracetamol for dengue fever: no benefit and potential harm?
Q92011762Pathogenesis and Immune Response Caused by Vector-Borne and Other Viral Infections in a Tupaia Model
Q35221052Performance of Simplexa dengue molecular assay compared to conventional and SYBR green RT-PCR for detection of dengue infection in Indonesia.
Q35103195Performance of commercial dengue NS1 ELISA and molecular analysis of NS1 gene of dengue viruses obtained during surveillance in Indonesia
Q36869547Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico.
Q40037926Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017.
Q34315171Physician survey to determine how dengue is diagnosed, treated and reported in puerto rico
Q26315462Physicians, Primary Caregivers and Topical Repellent: All Under-Utilised Resources in Stopping Dengue Virus Transmission in Affected Households
Q35043739Platelet activating factor contributes to vascular leak in acute dengue infection
Q26739670Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases
Q36455785Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool
Q55338916Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus.
Q33431047Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.
Q50751621Predicting ectotherm disease vector spread--benefits from multidisciplinary approaches and directions forward.
Q30836365Predicting local dengue transmission in Guangzhou, China, through the influence of imported cases, mosquito density and climate variability
Q21146686Predicting outcome from dengue
Q31065710Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data
Q35109205Predictive value of proteinuria in adult dengue severity
Q89840907Preparing for the dengue explosion in Kathmandu, Nepal
Q56000903Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis
Q38368332Prevention and Control Strategies to Counter Dengue Virus Infection
Q28729782Prevention and control of dengue-the light at the end of the tunnel
Q40037808Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques
Q61447814Probability of dengue transmission and propagation in a non-endemic temperate area: conceptual model and decision risk levels for early alert, prevention and control
Q90713910Production of tetravalent dengue virus envelope protein domain III based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development
Q40183703Profiling of esterified fatty acids as biomarkers in the blood of dengue fever patients using a microliter-scale extraction followed by gas chromatography and mass spectrometry.
Q58108919Prognostic Factors in Adult Patients with Dengue: Developing Risk Scoring Models and Emphasizing Factors Associated with Death ≤7 Days after Illness Onset and ≤3 Days after Presentation
Q40037516Progress and Challenges Towards Point-of-Care Diagnostic Development for Dengue.
Q56475810Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study
Q28954574Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial
Q40040540Prospective study of patients with persistent symptoms of dengue in Brazil
Q26314423Prospects for dengue vaccines for travelers
Q33414156Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
Q29616259Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Q34639275Proteomic biomarkers for ageing the mosquito Aedes aegypti to determine risk of pathogen transmission
Q30203504Prototype early warning systems for vector-borne diseases in Europe
Q90040456Pulmonary manifestations of dengue
Q24278786Quantifying the Epidemiological Impact of Vector Control on Dengue
Q59245626RNA helicase A is an important host factor involved in dengue virus replication
Q37670700RNA structures that resist degradation by Xrn1 produce a pathogenic Dengue virus RNA
Q40051947Rapid Evolution of Ovarian-Biased Genes in the Yellow Fever Mosquito (Aedes aegypti).
Q35120222Rapid diagnostic tests for dengue virus infection in febrile Cambodian children: diagnostic accuracy and incorporation into diagnostic algorithms.
Q36992653Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection
Q92048656Recent transmission of dengue virus and associated risk Facors among residents of Kassala state, eastern Sudan
Q34093421Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles
Q38975850Recommendations for the management of severe malaria and severe dengue in resource-limited settings
Q37109553Reduced risk of disease during postsecondary dengue virus infections
Q34374905Refining the global spatial limits of dengue virus transmission by evidence-based consensus
Q26771329Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review
Q38974932Repurposing of prochlorperazine for use against dengue virus infection
Q33429652Retracted: Serological and Entomological Study of Dengue in Dang and Chitwan Districts of Nepal
Q40082112Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus.
Q24261424Risk analysis for dengue suitability in Africa using the ArcGIS predictive analysis tools (PA tools)
Q39183973Risk assessment of dengue fever in Zhongshan, China: a time-series regression tree analysis.
Q35053872Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study
Q33997466Risk of dengue for tourists and teams during the World Cup 2014 in Brazil
Q36181531Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Q27927999Role of Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse) in local dengue epidemics in Taiwan
Q27003964Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth
Q42730574Roles of Interferons in Pregnant Women with Dengue Infection: Protective or Dangerous Factors.
Q88600737SELECTED EPIDEMICS & EMERGING PATHOGENS
Q26700096Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
Q33439772Safety and Efficacy of a Single Dose of Anti-D (WinRho®) in Severe Thrombocytopenia Secondary to Dengue Virus Infection
Q39468688Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
Q29197289Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study.
Q40235135Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA.
Q58787712Salivary Detection of Dengue Virus NS1 Protein with a Label-Free Immunosensor for Early Dengue Diagnosis
Q35640994Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion
Q39470840Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
Q37660743Secretory phospholipase A2 in the pathogenesis of acute dengue infection
Q36021379Sensitivity of the Dengue Surveillance System in Brazil for Detecting Hospitalized Cases
Q38334130Sensorineural hearing loss in hemorrhagic dengue?
Q66678780Serological inference of past primary and secondary dengue infection: implications for vaccination
Q99635679Seropositivity to dengue and associated risk factors among non-malarias acute febrile patients in Arba Minch districts, southern Ethiopia
Q36876526Seroprevalence of acute dengue in a Malaysian tertiary medical centre.
Q37050534Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection.
Q27468816Serum Procalcitonin and Peripheral Venous Lactate for Predicting Dengue Shock and/or Organ Failure: A Prospective Observational Study
Q97549435Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients
Q37414121Serum metabolomics analysis of patients with chikungunya and dengue mono/co-infections reveals distinct metabolite signatures in the three disease conditions.
Q90038071Severe dengue categories as research endpoints-Results from a prospective observational study in hospitalised dengue patients
Q33719688Severe neutropenia in dengue patients: prevalence and significance
Q34050264Signal propagation in multi-layer DNAzyme cascades using structured chimeric substrates
Q102075393Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19
Q35557524Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine.
Q46822697Skin dendritic cell and T cell activation associated with dengue shock syndrome
Q40227094Skin rash from dengue fever
Q36052251Slow resolution of inflammation in severe adult dengue patients
Q56881264Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008
Q38773323Status of vaccine research and development of vaccines for dengue
Q38045106Structural biology of dengue virus enzymes: towards rational design of therapeutics
Q37145822Subacute bilateral vision loss resulting from dengue maculopathy
Q33414560Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice
Q34990697Suppression of virus specific immune responses by IL-10 in acute dengue infection
Q37713941Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum
Q40204994Survival of larvivorous fish used for biological control of Aedes aegypti (Diptera: Culicidae) combined with different larvicides
Q92909202Systematic review of dengue vaccine efficacy
Q90461580TIM-1 As a Signal Receptor Triggers Dengue Virus-Induced Autophagy
Q24288867Tackling dengue fever: Current status and challenges
Q37611829Targeting host factors to treat West Nile and dengue viral infections
Q91901533Teaching Pediatric Life Support in Limited-Resource Settings: Contextualized Management Guidelines
Q28533629Temephos resistance in Aedes aegypti in Colombia compromises dengue vector control
Q33681310Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
Q34535311Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children
Q33747338The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications
Q28954726The Complement System in Flavivirus Infections
Q36206719The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.
Q59360089The Development of Peptide-based Antimicrobial Agents against Dengue Virus
Q28657506The Emerging Zika Virus Threat: A Guide for Dermatologists
Q57146464The Estimates of the Health and Economic Burden of Dengue in Vietnam
Q63740761The First Outbreak of Dengue Fever in Greater Darfur, Western Sudan
Q35858397The Hidden Burden of Dengue and Chikungunya in Chennai, India
Q35877565The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective
Q89805021The Mosquito Larvicidal Activity of Essential Oils from Cymbopogon and Eucalyptus Species in Vietnam
Q63246434The Organization, Implementation, and Functioning of Dengue Surveillance in India-A Systematic Scoping Review
Q54257287The Tolerability and Efficacy of Oral Isotonic Solution versus Plain Water in Dengue Patients: A Randomized Clinical Trial.
Q35594746The burden of dengue and chikungunya worldwide: implications for the southern United States and California
Q34006711The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis
Q36978907The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability
Q35340980The deadly ebola threat in the midst of an overwhelming dengue epidemic
Q40249733The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya
Q37547030The exploration of risk factors of concurrent bacteraemia in patients critically ill with severe dengue
Q52345950The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
Q28388682The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
Q33945536The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases
Q24628768The global distribution and burden of dengue
Q22680660The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
Q34522607The global economic burden of dengue: a systematic analysis
Q56000961The impact of the age of first blood meal and Zika virus infection on Aedes aegypti egg production and longevity
Q38772810The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection.
Q56378131The role of lipids in the inception, maintenance and complications of dengue virus infection
Q35496004The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial
Q35849296The use of rapid dengue diagnostic tests in a routine clinical setting in a dengue-endemic area of Colombia
Q33441421The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue
Q38149195Therapeutic antibodies as a treatment option for dengue fever
Q34431491Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials
Q33423030Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators
Q28954686Time to stop prophylactic platelet transfusion for adult dengue
Q33854218Time-varying, serotype-specific force of infection of dengue virus
Q36112987Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections
Q89495203Transient Expression of Dengue Virus NS1 Antigen in Nicotiana benthamiana for Use as a Diagnostic Antigen
Q36444531Trends in Dengue Cases Imported into the United States from Pan America 2001-2012
Q28074355Trends in clinical trials of dengue vaccine
Q30145525Trends of Dengue Disease Epidemiology
Q26829882Two cases of false-positive dengue non-structural protein 1 (NS1) antigen in patients with hematological malignancies and a review of the literature on the use of NS1 for the detection of Dengue infection
Q40033679Two disciplines, one priority: the seamless integration of human and veterinary microbiology is urgent
Q33744074Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines
Q54226258Understanding dengue virus evolution to support epidemic surveillance and counter-measure development.
Q38288358Unusual Presentation of Dengue Fever: A child with acute myocarditis.
Q40218361Unusual and rare manifestations of dengue during a dengue outbreak in a tertiary care hospital in South India
Q35072070Unusual presentation of chikungunya virus infection with concomintant erysipelas in a returning traveler from the Caribbean: a case report
Q92839467Upregulation of SCUBE1 in Dengue Virus Infection
Q33884602Urban Chikungunya in the Middle East and North Africa: A systematic review
Q38126179Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention
Q36157629Use of Warning Signs for Dengue by Pediatric Health Care Staff in Brazil
Q34600668Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis
Q33418844Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room
Q40277788Use of the tourniquet test in diagnosing dengue-like syndrome
Q56417600Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji
Q35889724Utility of C-Reactive Protein Levels for Early Prediction of Dengue Severity in Adults
Q42355484VERTICAL TRANSMISSION OF DENGUE INFECTION: THE FIRST PUTATIVE CASE REPORTED IN CHINA.
Q104692319Vaccination coverage and adherence to a dengue vaccination program in the state of Paraná, Brazil
Q24288750Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens
Q39409129Vascular leakage in dengue--clinical spectrum and influence of parenteral fluid therapy
Q99565737Vector-borne diseases in pregnancy
Q28080121Viral arthritis
Q36082908Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis
Q34722636Worldwide spread of Dengue virus type 1.
Q58276963Zika Virus
Q33433912Zika Virus Infection Associated With Severe Thrombocytopenia
Q43046770Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens
Q90040682Zika virus infection in the genital tract of non-pregnant females: a systematic review
Q38156532Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases
Q40142502microRNA expression in blood of dengue patients

Search more.